H. Hatcher

发表

Clinical trial designs for rare diseases: Studies developed and discussed by the International Rare Cancers Initiative

J. Blay, M. Sydes, A. Benson, 2015, European journal of cancer.

Management of solid tumours in organ-transplant recipients.

C. Parkinson, H. Hatcher, A. Butler, 2007, The Lancet. Oncology.

S. Barclay, M. McCabe, F. Gibson, 2017, Journal of adolescent and young adult oncology.

Borderline Sarcomas and Smooth Muscle Tumours of Uncertain Malignant Potential.

G. Horan, S. Prewett, H. Hatcher, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Multidisciplinary Management of Sarcomas - Where Are We Now?

H. Hatcher, T. Ajithkumar, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Systemic Treatments in Soft Tissue Sarcomas.

H. Hatcher, T. Ajithkumar, C. Benson, 2017, Clinical oncology (Royal College of Radiologists (Great Britain)).

Teenage and Young Adult Cancer-Related Fatigue Is Prevalent, Distressing, and Neglected: It Is Time to Intervene. A Systematic Literature Review and Narrative Synthesis.

S. Barclay, H. Hatcher, I. Kuhn, 2015, Journal of adolescent and young adult oncology.

Pazopanib, a promising option for the treatment of aggressive fibromatosis

Robin L. Jones, I. Judson, Z. Szucs, 2017, Anti-cancer drugs.

Presentation and management of pulmonary artery sarcoma

H. Earl, G. Horan, H. Wong, 2015, Clinical Sarcoma Research.

Management of Malignant Ovarian Germ Cell Tumors

C. Parkinson, H. Hatcher, T. Ajithkumar, 2011, Obstetrical & gynecological survey.

Selinexor in Advanced, Metastatic Dedifferentiated Liposarcoma: A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial

Robin L. Jones, J. Blay, K. Götze, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multidisciplinary management of malignant ovarian germ cell tumours.

H. Earl, C. Parkinson, H. Hatcher, 2011, Gynecologic oncology.

This is a repository copy of A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line

Robin L. Jones, I. Ray-Coquard, B. Seddon, 2020 .

Lorlatinib for the treatment of inflammatory myofibroblastic tumour with TPM4-ALK fusion following failure of entrectinib

G. Horan, James Watkins, H. Wong, 2020, Anti-cancer drugs.

How Can Health Care Professionals Communicate Effectively with Adolescent and Young Adults Who Have Completed Cancer Treatment? A Systematic Review.

H. Hatcher, Luke A M Smith, Debbie Critoph, 2020, Journal of adolescent and young adult oncology.

Desmoplastic small round cell tumour: characteristics and prognostic factors of 41 patients and review of the literature

H. Earl, C. Fisher, I. Judson, 2013, Clinical Sarcoma Research.

A Comprehensive Single Institutional Review of 2 Years in a Designated Fast-Track Sarcoma Diagnostic Clinic Linked with a Sarcoma Specialist Advisory Group: Meeting the Target but Failing the Task?

H. Earl, R. Grimer, G. Horan, 2016, Sarcoma.

Trabectedin for advanced soft tissue sarcomas: a single institution experience.

H. Earl, G. Horan, H. Hatcher, 2014, Future oncology.

Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast Cancer

R. Laing, R. Plummer, M. Uttenreuther-Fischer, 2014, Clinical Cancer Research.

A randomized double-blind phase II study evaluating the role of maintenance therapy with cabozantinib in high-grade uterine sarcoma after stabilization or response to doxorubicin ± ifosfamide following surgery or in metastatic first line treatment (EORTC62113)

Robin L. Jones, P. Casali, I. Ray-Coquard, 2020, International Journal of Gynecological Cancer.

Adjuvant Gemcitabine Plus Docetaxel Followed by Doxorubicin Versus Observation for High-Grade Uterine Leiomyosarcoma: A Phase III NRG Oncology/Gynecologic Oncology Group Study.

Danielle M. Enserro, J. Blay, K. Robison, 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of wild‐type gastrointestinal stromal tumor (WT‐GIST) with imatinib and sunitinib

I. Judson, N. Carroll, M. Murray, 2008, Pediatric blood & cancer.

A review of the surgical management of metastatic gastrointestinal stromal tumours (GISTs) on imatinib mesylate (Glivec).

H. Earl, R. Hardwick, V. Save, 2005, International journal of surgery.

Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients.

H. Earl, L. Whitehead, G. Whitfield, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant gemcitabine plus docetaxel followed by doxorubicin versus observation for uterus-limited, high-grade leiomyosarcoma: A phase III GOG study.

Danielle M. Enserro, J. Blay, K. Robison, 2018 .

A phase I study of S-222611 an oral reversible dual inhibitor of EGFR and HER2, in patients with solid tumors.

R. Plummer, E. Frenkel, M. Jamal-Hanjani, 2012 .

Documentation of Oncofertility Communication in Adolescents and Young Adults with Cancer: A Retrospective Analysis.

H. Hatcher, S. Heritage, M. Mourad, 2021, Journal of adolescent and young adult oncology.

Epirubicin, Cisplatin, and Capecitabine for Primary Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer

J. Abraham, H. Earl, C. Parkinson, 2015, International Journal of Gynecologic Cancer.

RECIST and Choi criteria for response assessment (RA) in patients with inoperable and metastatic gastrointestinal stromal tumours (GISTs) on imatinib mesylate. Cambridge GIST study group experience

H. Earl, R. Hardwick, V. Save, 2007 .

Anticancer chemotherapy in teenagers and young adults: managing long term side effects

H. Hatcher, T. Ajithkumar, M. Reinius, 2016, British Medical Journal.

Non‐pineal supratentorial primitive neuro‐ectodermal tumors (sPNET) in teenagers and young adults: Time to reconsider cisplatin based chemotherapy after cranio‐spinal irradiation?

H. Earl, N. Burnet, G. Horan, 2009, Pediatric blood & cancer.

13 – Cancers of the female genital system

C. Parkinson, H. Hatcher, T. Ajithkumar, 2011 .

Cambridge Translational Cancer Research Ovarian Study 01 (CTCR-OV01): Expression profiling of advanced epithelial ovarian cancer (EOC) to predict chemotherapy response. A randomised phase II trial design with prospective translational endpoints.

H. Earl, C. Parkinson, J. Brenton, 2006, Journal of Clinical Oncology.

Cardiotoxicity with trabectedin in the treatment of advanced soft tissue sarcoma

G. Doherty, H. Wong, H. Hatcher, 2019, Anti-cancer drugs.

Mimics of gastrointestinal stromal tumors (GISTs): Implications for diagnosis and management—The Cambridge GIST Study Group (CGSG) experience.

H. Earl, R. Hardwick, G. Horan, 2013 .

Phase I Study to Assess the Combination of Afatinib with Trastuzumab in Patients with Advanced or Metastatic HER2-Positive Breast Cancer

R. Laing, R. Plummer, M. Uttenreuther-Fischer, 2014, Clinical Cancer Research.

Teenage and Young Adult Cancer-Related Fatigue Is Prevalent, Distressing, and Neglected: It Is Time to Intervene. A Systematic Literature Review and Narrative Synthesis.

S. Barclay, H. Hatcher, I. Kuhn, 2015, Journal of adolescent and young adult oncology.